Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 17 (4), 223-238

Liquid Biopsies Come of Age: Towards Implementation of Circulating Tumour DNA

Affiliations
Review

Liquid Biopsies Come of Age: Towards Implementation of Circulating Tumour DNA

Jonathan C M Wan et al. Nat Rev Cancer.

Abstract

Improvements in genomic and molecular methods are expanding the range of potential applications for circulating tumour DNA (ctDNA), both in a research setting and as a 'liquid biopsy' for cancer management. Proof-of-principle studies have demonstrated the translational potential of ctDNA for prognostication, molecular profiling and monitoring. The field is now in an exciting transitional period in which ctDNA analysis is beginning to be applied clinically, although there is still much to learn about the biology of cell-free DNA. This is an opportune time to appraise potential approaches to ctDNA analysis, and to consider their applications in personalized oncology and in cancer research.

Similar articles

See all similar articles

Cited by 257 PubMed Central articles

See all "Cited by" articles

References

    1. Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):67-71 - PubMed
    1. Oncotarget. 2016 Nov 8;:null - PubMed
    1. Nucleic Acids Res. 2016 Jan 8;44(1):1-13 - PubMed
    1. Sci Transl Med. 2015 Nov 11;7(313):313ra182 - PubMed
    1. Br J Cancer. 2014 Jan 7;110(1):55-62 - PubMed
Feedback